{
  "data": {
    "broad_sector": "PHARMA",
    "niche_industry": "Branded Generics (Chronic & Sub-chronic Therapies)",
    "sector_kpis": {
      "kpi_1": "EBITDA Margin: 32.8%",
      "kpi_2": "Domestic Revenue Contribution: 53%",
      "kpi_3": "R&D Spend: 5.0% of Sales"
    },
    "moat_rating": "Narrow",
    "competitive_position": "CHALLENGER"
  },
  "_cached_at": "2025-12-31T13:14:27.274026",
  "_symbol": "TORNTPHARM"
}